NCT06728956 Assessing NHS ImplemeNTation of an onlinE Resilience Training Acceptance and Commitment Therapy (ACT) Programme to Prevent Job Loss in Multiple Sclerosis
| NCT ID | NCT06728956 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Leeds Teaching Hospitals NHS Trust |
| Condition | Multiple Sclerosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-06-14 |
| Primary Completion | 2027-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2024-06-14 with a primary completion date of 2027-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
People with MS (PwMS) are at increased risk of leaving work earlier than expected. Psychological factors that affect PwMS may make it more difficult to manage staying in work. These can include psychological flexibility and self efficacy. Psychological flexibility is the ability to effectively manage unwanted inner experiences (e.g., thoughts, memories, bodily sensations) in the present. Self-efficacy is the self-belief that an individual has in their ability to succeed.
Eligibility Criteria
Inclusion Criteria: * Participants capable of giving informed consent * Age 18 years or above * Currently in paid employment with an intention to remain in employment for at least 6 months * Phase 2: A registered healthcare professional or allied health professional who works in direct contact with patients diagnosed with Multiple Sclerosis OR * Phase 3: An individual with a clinical diagnosis of Multiple Sclerosis and reporting a WI score ≥11/22 (on MS-WIS) Exclusion Criteria: * Individuals lacking capacity to give informed consent * Individuals intending to leave paid employment within the next 6 months * Individuals who will not have access to a device used to access the internet (e.g. laptop or smartphone) for the duration of study participation
Frequently Asked Questions
Who can join the NCT06728956 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 66 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06728956 currently recruiting?
Yes, NCT06728956 is actively recruiting participants. Visit ClinicalTrials.gov or contact The Leeds Teaching Hospitals NHS Trust to inquire about joining.
Where is the NCT06728956 trial being conducted?
This trial is being conducted at Leeds, United Kingdom.
Who is sponsoring the NCT06728956 clinical trial?
NCT06728956 is sponsored by The Leeds Teaching Hospitals NHS Trust. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.